Strs Ohio reports 5.26% decrease in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated

IT ˙ BIT ˙ US92532F1003

366,30 € ↓ -1,30 (-0,35%)

2026-06-03
AKTIENPREIS

Security	IT:1VRTX / Vertex Pharmaceuticals Incorporated
Institution	Strs Ohio
Latest Disclosed Ownership	74,163 shares
Latest Disclosed Value	$ 33,116,746

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 74,163 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $28,152,275 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 78,278 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -5.26% during the quarter. The current value of the position is $27,165,907 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-24	2026-03-31	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	74,163	-4,115	-5.26	33,117	-6.68	0.1314
2026-02-02	2025-12-31	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	78,278	-2,347	-2.91	35,488	12.39	0.1324
2025-10-30	2025-09-30	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	80,625	-32,133	-28.50	31,576	-37.10	0.1158
2025-08-04	2025-06-30	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	112,758	34,907	44.84	50,200	33.00	0.1874
2025-05-28	2025-03-31	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	77,851	-680	-0.87	37,744	19.35	0.1581
2025-05-28	2024-12-31	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	78,531	-9,807	-11.10	31,624	-23.03	0.1254
2024-11-01	2024-09-30	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	88,338	-1,371	-1.53	41,084	-2.29	0.1581
2024-08-05	2024-06-30	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	89,709	-3,229	-3.47	42,048	110,552.63	0.1661
2024-05-13	2024-03-31	13F	VERTEX PHARMACEUTICALS	COM_STK	92532F100	92,938	-5,015	-5.12	39	-2.56	0.1548
2024-01-30	2023-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	97,953	-4,161	-4.07	40	11.43	0.1659
2023-10-26	2023-09-30	13F/A-1	VERTEX PHARMAREUTICALS	COM	92532F100	102,114	-3,011	-2.86	36	-2.78	0.1581
2023-10-26	2023-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	102,114	-3,011		36		0.1581
2023-07-31	2023-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	105,125	-4,344	-3.97	37	5.88	0.1562
2023-08-02	2023-03-31	13F/A-2	VERTEX PHARMAREUTICALS	COM	92532F100	109,469	131	0.12	34	9.68	0.1494
2023-08-02	2023-03-31	13F/A-1	VERTEX PHARMAREUTICALS	COM	92532F100	109,469	131		34		0.1494
2023-04-27	2023-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	109,469	131		34		0.1780
2023-01-26	2022-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	109,338	-6,357	-5.49	32	-99.91	0.1426
2022-10-27	2022-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	115,695	-586	-0.50	33,498	2.23	0.1596
2022-07-25	2022-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	116,281	-1,357	-1.15	32,766	6.73	0.1476
2022-04-21	2022-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	117,638	8,207	7.50	30,699	27.75	0.1123
2022-01-24	2021-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	109,431	-2,688	-2.40	24,031	18.16	0.0834
2021-10-22	2021-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	112,119	-7,461	-6.24	20,337	-15.65	0.0765
2021-07-26	2021-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	119,580	-559	-0.47	24,110	-6.61	0.0867
2021-04-23	2021-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	120,139	-10,159	-7.80	25,816	-16.17	0.0972
2021-01-25	2020-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	130,298	-153,194	-54.04	30,794	-60.08	0.1188
2020-12-14	2020-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	283,492	-30,232	-9.64	77,143	-15.30	0.3230
2020-07-23	2020-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	313,724	-11,685	-3.59	91,077	17.62	0.3980
2020-04-23	2020-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	325,409	-7,266	-2.18	77,431	6.30	0.4076
2020-01-24	2019-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	332,675	-7,246	-2.13	72,839	26.48	0.3051
2019-10-21	2019-09-30	13F/A-1	VERTEX PHARMAREUTICALS	COM	92532F100	339,921	-2,046	-0.60	57,589	-8.16	0.2525
2019-10-21	2019-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	339,921	7,246		57,589		254,892.1080
2019-07-25	2019-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	341,967	284	0.08	62,709	-0.23	0.2788
2019-04-19	2019-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	341,683	578	0.17	62,852	11.20	0.2849
2019-01-23	2018-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	341,105	1,056	0.31	56,524	-13.76	0.2870
2018-10-19	2018-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	340,049	-32,193	-8.65	65,541	3.60	0.2874
2018-08-06	2018-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	372,242	-9,929	-2.60	63,266	1.57	0.2723
2018-04-20	2018-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	382,171	-9,650	-2.46	62,286	6.08	0.2754
2018-01-23	2017-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	391,821	13,232	3.50	58,718	2.01	0.2509
2017-10-23	2017-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	378,589	38,724	11.39	57,560	31.42	0.2471
2017-07-26	2017-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	339,865	5,824	1.74	43,798	19.91	0.1951
2017-04-26	2017-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	334,041	-3,674	-1.09	36,527	46.82	0.1582
2017-01-24	2016-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	337,715	-25,604	-7.05	24,879	-21.48	0.1096
2016-10-27	2016-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	363,319	16,980	4.90	31,685	6.35	0.1415
2016-07-26	2016-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	346,339	31,241	9.91	29,792	18.94	0.1324
2016-04-25	2016-03-31	13F/A-1	VERTEX PHARMAREUTICALS	COM	92532F100	315,098	15,531	5.18	25,047	-33.55	0.1125
2016-01-28	2015-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	299,567	179	0.06	37,694	20.90	0.1686
2015-10-21	2015-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	299,388	1,232	0.41	31,178	-15.31	0.1483
2015-08-04	2015-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	298,156	11,087	3.86	36,816	8.71	0.1616
2015-04-27	2015-03-31	13F/A-1	VERTEX PHARMAREUTICALS	COM	92532F100	287,069	280,428	4,222.68	33,865	4,192.14	0.1494
2015-04-21	2015-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	33,865,530			33,385
2015-01-23	2014-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	6,641	4,285	181.88	789	197.74	0.0034
2014-10-29	2014-09-30	13F/A-1	VERTEX PHARMAREUTICALS	COM	92532F100	2,356	0	0.00	265	18.83	0.0012
2014-10-20	2014-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	2,356			265
2014-07-24	2014-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	2,356	0	0.00	223	33.53	0.0010
2014-04-28	2014-03-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	2,356	0	0.00	167	-4.57	0.0008
2014-01-30	2013-12-31	13F	VERTEX PHARMAREUTICALS	COM	92532F100	2,356	0	0.00	175	-2.23	0.0008
2013-10-24	2013-09-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	2,356	2,148	1,032.69	179	952.94	0.0008
2013-08-12	2013-06-30	13F	VERTEX PHARMAREUTICALS	COM	92532F100	208	208		17		0.0001

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.